Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


  • The Ruskell Medal, The Worshipful Company of Spectacle Makers, 2021
  • The Founder's Cup, Oxford Ophthalmological Congress, 2018
  • Fellow of the Royal College of Ophthalmologists, 2016
  • MRC/Fight for Sight Clinical Research Training Fellowship2015
  • Crombie Medal, Royal College of Ophthalmologists 2011
  • BM BCh with Distinction, University of Oxford 2010
  • MA (First Class), University of Cambridge 2007
  • Swann Prize for Biology, Gonville & Caius College, Cambridge 2007
  • Ian Gordon-Smith Prize for Medicine, Gonville & Caius College, Cambridge 2005

Harry Orlans

MA (Cantab) BM BCh DPhil FRCOphth

Clinical Research Fellow

  • Specialist Registrar and Locum Consultant (Accident & Emergency), Moorfields Eye Hospital, London

Harry's background is in Clinical Ophthalmology as a Specialist Registrar within the North London/Moorfields Eye Hospital training rotation. 

Harry's research focusses on developing a new gene-therapy based treatment for dominant retinitis pigmentosa (RP) caused by defects in the rhodopsin gene. These mutations account for around a quarter of all cases of dominant RP and are one of the most common genetic cause of sight loss in the UK.